NKGen Biotech, Inc.

Historical 13F Holders

Symbol
NKGN
CUSIP
65488A101
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 65488A101 since 12/18/2024, largest first.

Filer % of Class Filed
Paul Y. Song 13D 54.3% 5/12/2025
Event 5/5/2025
CFIC-2015 NV Family Investments, LLC 13D
47.2% 6/2/2025
Event 5/27/2025
Pathstone Family Office, LLC 13G 7.9% 2/28/2025
Event 10/17/2024
Meteora Capital, LLC 13G/A
6.1% 5/15/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 1 2.76 M $165 k
2026 Q1 1 2.76 M $193 k
2025 Q4 1 2.76 M $138 k
2025 Q3 1 2.76 M $303 k
2025 Q1 3 892 k $161 k
2024 Q4 26 8.35 M $5.07 M
2024 Q3 21 3.75 M $1.23 M
2024 Q2 18 3.42 M $4.24 M
2024 Q1 14 3.02 M $5.66 M
2023 Q4 11 5.35 M $18.1 M